The clinicopathological significance of HES1 promoter hypomethylation in patients with colorectal cancer
Yinfang Wu,1,* Lijie Gong,1,* Ji Xu,1,2 Yiping Mou,1,2 Xiaowu Xu,1,2 Zhenyuan Qian1,2 1Department of Gastrointestinal and Pancreatic Surgery, Zhejiang Provincial People’s Hospital, People’s Hospital of Hangzhou Medical College, Hangzhou, Zhejiang, 2Key Laboratory of Gastroentero...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2017-12-01
|
| Series: | OncoTargets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/the-clinicopathological-significance-of-hes1-promoter-hypomethylation--peer-reviewed-article-OTT |